24
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Lack of Efficacy of 2-Chlorodeoxyadenoside in the Treatment of Splenic Lymphoma with Villous Lymphocytes

, , , , , , , & show all
Pages 113-117 | Received 20 Mar 2000, Published online: 01 Jul 2009

References

  • Melo J. V., Hedge U., Parreira A., Thompson I., Lampert I. A., Catovsky D. Splenic B-cell lymphoma with circulating villous lymphocytes: differential diagnosis of B-cell leukaemia with large spleens. Journal of Clinical Pathology 1987; 40: 642–645
  • Matutes E., Morilla R., Owusu-Ankomah K., Houliham A., Meeus P., Catovsky D. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leukemia and Lymphoma 1994; 14, (Suppl 1), 57-61
  • Isaacson P., Matutes E., Burke M., Catovsky D. The histopathology of splenic lymphoma with villous lymphocyte's. Blood 1994; 84: 3828–3834
  • Troussard X., Mauvieux L., Radfort-Weiss I., Rack K., Valensi F., Garand R., Vekemans M., Plandrin G., Macintyre E. Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Francais d'Hématologie Cellulaire (GFHC) study. British Journal of Haematology 1998; 101, 712-721
  • Troussard X., Valensi F., Duchayne E., Garand R., Felman P., Tulliez M., Henry-Amar M., Bryon P. A., Flandrin G. Splenic lymphoma with villous lymphocytes: a clinical presentation, biology and prognosis factors in a series of 100 patients. British Journal of Haematology 1996; 93: 731–736
  • Matutes E., Morilla R., Owusu-Ankomah K., Houlihan A., Catovsky D. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 1994; 83: 1558–1562
  • Mulligan S. P., Matutes E., Dearden C., Catovsky D. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. British Journal of Haematology 1991; 78: 206–209
  • Tallman M. S., Hakimian D. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood 1995; 86: 2463–2474
  • Robak T., Blasinska-Morawiec M., Blonski J. Z., Dmoszynska A. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia. Leukemia and Lymphoma 1999; 34: 151–157
  • Virchis A., Mehta A. Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenoside (2-Cda). British Journal of Haematology 1998; 100: 609
  • Bolam S., Orchard J., Oscier D. Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes. British Journal of Haematology 1997; 99: 158–161
  • LefrÈRe P., Hermine O., Belanger C., FranÇOis S., Lebas De La Cour JC, Valensi F., Varet B., Troussard X. Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes. Leukemia 2000; 14: 573–575

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.